Lysosomal alpha-glucosidase
Also known as: GAA
Function
Essential for the degradation of glycogen in lysosomes. Has highest activity on alpha-1,4-linked glycosidic linkages, but can also hydrolyze alpha-1,6-linked glucans.
Classification
- Family (Pfam)
- PF13802 Gal_mutarotas_2, PF01055 Glyco_hydro_31_2nd, PF21365 Glyco_hydro_31_3rd, PF00088 Trefoil
- InterPro
- Gal_mutarotase_sf_dom, GH, Glyco_hydro_31_AS, Glyco_hydro_31_C, Glyco_hydro_31_CS, Glyco_hydro_31_N_dom, Glyco_hydro_31_TIM, Glyco_hydro_b, P_trefoil_CS, P_trefoil_dom, P_trefoil_dom_sf
- Functional cluster
- Secreted Growth Factors & Cytokines
Experimental structures · PDB · 19
- 5KZW X-ray 2.00A
- 5KZX X-ray 2.00A
- 5NN3 X-ray 1.90A
- 5NN4 X-ray 1.83A
- 5NN5 X-ray 2.00A
- 5NN6 X-ray 2.00A
- 5NN8 X-ray 2.45A
- 7P2Z X-ray 1.85A
- 7P32 X-ray 1.82A
- 8CB1 X-ray 1.75A
- 8CB6 X-ray 1.90A
- 9GSV X-ray 1.80A
- … and 7 more
A predicted model is available from AlphaFold.
Gene Ontology · 21
- GO:0120282 autolysosome lumen
- GO:0035577 azurophil granule membrane
- GO:0070062 extracellular exosome
- GO:0101003 ficolin-1-rich granule membrane
- GO:0043202 lysosomal lumen
- GO:0005765 lysosomal membrane
- GO:0005764 lysosome
- GO:0016020 membrane
- GO:0005886 plasma membrane
- GO:0070821 tertiary granule membrane
- GO:0004558 alpha-1,4-glucosidase activity
- GO:0090599 alpha-glucosidase activity
- GO:0030246 carbohydrate binding
- GO:0043896 glucan 1,6-alpha-glucosidase activity
- GO:0002086 diaphragm contraction
- GO:0006006 glucose metabolic process
- GO:0005980 glycogen catabolic process
- GO:0061723 glycophagy
- GO:0007040 lysosome organization
- GO:0000023 maltose metabolic process
- GO:0005985 sucrose metabolic process
Disease associations
Drugs targeting this protein · 4
- MIGLITOL inhibitor
- CELGOSIVIR inhibitor
- DUVOGLUSTAT HYDROCHLORIDE stabiliser
- VOGLIBOSE inhibitor
Related proteins · sequence + function similarity
- Lysosomal alpha-glucosidase 0.99
- Lysosomal alpha-glucosidase 0.99
- Lysosomal alpha-glucosidase 0.97
- Lysosomal alpha-glucosidase 0.96
- Neutral alpha-glucosidase AB 0.91
- Neutral alpha-glucosidase AB 0.91
- Neutral alpha-glucosidase AB 0.90
- Neutral alpha-glucosidase AB 0.88
- Lysosomal alpha-mannosidase 0.77
- Lysosomal alpha-mannosidase 0.76
- Lysosomal alpha-mannosidase 0.76
- Tissue alpha-L-fucosidase 0.75
Co-cited proteins · studied together in the literature
- Transmembrane protein 192 1 shared papers
- Lysosomal membrane ascorbate-dependent ferrireductase CYB561A3 1 shared papers
- Vacuolar fusion protein CCZ1 homolog B 1 shared papers
- Glycosylated lysosomal membrane protein 1 shared papers
- Regulator of MON1-CCZ1 complex 1 shared papers
- Prostatic acid phosphatase 1 shared papers
- Proton-coupled amino acid transporter 1 1 shared papers
- Vacuolar fusion protein CCZ1 homolog 1 shared papers
- Solute carrier family 15 member 3 1 shared papers
- E3 ubiquitin-protein ligase RNF13 1 shared papers
- Sodium-independent sulfate anion transporter 1 shared papers
- Vesicle-associated membrane protein 7 1 shared papers
Literature · 61 cited papers
- Structure of human lysosomal acid alpha-glucosidase-a guide for the treatment of Pompe disease. Nat. Commun. · 2017
- N-terminome analysis of the human mitochondrial proteome. Proteomics · 2015
- Novel GAA mutations in patients with Pompe disease. Gene · 2015
- An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J. Proteomics · 2014
- A cross-sectional single-centre study on the spectrum of Pompe disease, German patients: molecular analysis of the GAA gene, manifestation and genotype-phenotype correlations. Orphanet J. Rare Dis. · 2012
- Update of the pompe disease mutation database with 60 novel GAA sequence variants and additional studies on the functional effect of 34 previously reported variants. Hum. Mutat. · 2012
- Initial characterization of the human central proteome. BMC Syst. Biol. · 2011
- Late form of Pompe disease with glycogen storage in peripheral nerves axons. J. Neurol. Sci. · 2011
- Screening of late-onset Pompe disease in a sample of Mexican patients with myopathies of unknown etiology: identification of a novel mutation in the acid alpha-glucosidase gene. J. Child Neurol. · 2010
- Genetic heterozygosity and pseudodeficiency in the Pompe disease newborn screening pilot program. Mol. Genet. Metab. · 2010
- Pompe disease in a Brazilian series: clinical and molecular analyses with identification of nine new mutations. J. Neurol. · 2009
- Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry. J. Proteome Res. · 2009
- … and 49 more in the literature graph
A document in the lmmol reference corpus — open public data (UniProt, GO, PDB, the literature graph) rendered as a single cross-linked page. Hover any link to preview its target.